Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible T?RI cross-talk in diffuse intrinsic pontine glioma.

ABSTRACT: Diffuse intrinsic pontine glioma (DIPG) is a lethal pediatric brain cancer whose median survival time is under one year. The possible roles of the two most common DIPG associated cytoplasmic ACVR1 receptor kinase domain mutants, G328V and R206H, are reexamined in the context of new biochemical results regarding their intrinsic relative ATPase activities. At 37?°C, the G328V mutant displays a 1.8-fold increase in intrinsic kinase activity over wild-type, whereas the R206H mutant shows similar activity. The higher G328V mutant intrinsic kinase activity is consistent with the statistically significant longer overall survival times of DIPG patients harboring ACVR1 G328V tumors. Based on the potential cross-talk between ACVR1 and T?RI pathways and known and predicted off-targets of ACVR1 inhibitors, we further validated the inhibition effects of several T?RI inhibitors on ACVR1 wild-type and G328V mutant patient tumor derived DIPG cell lines at 20-50?µM doses. SU-DIPG-IV cells harboring the histone H3.1K27M and activating ACVR1 G328V mutations appeared to be less susceptible to T?RI inhibition than SF8628 cells harboring the H3.3K27M mutation and wild-type ACVR1. Thus, inhibition of hidden oncogenic signaling pathways in DIPG such as T?RI that are not limited to ACVR1 itself may provide alternative entry points for DIPG therapeutics.

SUBMITTER: Cao H 

PROVIDER: S-EPMC7145857 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature